Mangoceuticals raises $1.2M in public offering of 4M shares at $0.30 per share

MANGOCEUTICALS, INC.

Priced public offering of 4,000,000 shares at $0.30 per share for gross proceeds of $1,200,000.
Closed on Dec 19, 2023; net proceeds approximately $1.0 million after underwriting discounts and expenses.
Granted underwriter Boustead Securities a warrant to purchase 280,000 shares at $0.38, exercisable until Dec 14, 2029.
Proceeds to fund marketing of Mango ED and GROW hair growth products, hiring, software development, and working capital.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

MANGOCEUTICALS, INC. entered into Underwriting Agreement with Boustead Securities, LLC, as representative of the underwriters valued at $1.2 million (effective 2023-12-15).

Action: entry
Agreement: underwriting
Counterparty: Boustead Securities, LLC, as representative of the underwriters
Value: $1.2 million
Effective: 2023-12-15

Exact text from the filing

On December 15, 2023, Mangoceuticals, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Boustead Securities, LLC, as representative (the “ Representative ”) of the underwriters named on Schedule 1 thereto (the “ Underwriters ”), relating to a public offering of the Company’s common stock (the “ Offering ”).

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

MANGOCEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-045420

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.